Opthea Ltd (OPT)
3.41
+0.14
(+4.28%)
USD |
NASDAQ |
Apr 30, 13:08
Opthea Cash from Financing (TTM): 138.48M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 138.48M |
June 30, 2023 | 167.29M |
December 31, 2022 | 167.16M |
June 30, 2022 | 0.1716M |
December 31, 2021 | 0.1819M |
June 30, 2021 | 116.94M |
December 31, 2020 | 115.78M |
June 30, 2020 | 33.17M |
December 31, 2019 | 34.53M |
June 30, 2019 | 9.070M |
December 31, 2018 | 9.078M |
June 30, 2018 | 0.4038M |
December 31, 2017 | 33.57M |
June 30, 2017 | 33.36M |
December 31, 2016 | 0.0077M |
June 30, 2016 | 0.0031M |
December 31, 2015 | -0.8186M |
June 30, 2015 | 12.31M |
December 31, 2014 | |
June 30, 2014 | |
December 31, 2013 | |
June 30, 2013 | |
December 31, 2012 | |
June 30, 2012 | |
December 31, 2011 |
Date | Value |
---|---|
June 30, 2011 | |
December 31, 2010 | |
June 30, 2010 | |
December 31, 2009 | |
June 30, 2009 | |
December 31, 2008 | |
June 30, 2008 | -0.1048M |
December 31, 2007 | 0.5691M |
June 30, 2007 | 0.5765M |
December 31, 2006 | -0.0571M |
June 30, 2006 | -3.721M |
December 31, 2005 | -7.993M |
June 30, 2005 | -15.96M |
December 31, 2004 | -11.61M |
June 30, 2004 | -0.3421M |
December 31, 2003 | -1.407M |
June 30, 2003 | -0.9836M |
December 31, 2002 | 0.0752M |
June 30, 2002 | 0.0651M |
December 31, 2001 | -0.6878M |
June 30, 2001 | 12.17M |
December 31, 2000 | 22.41M |
June 30, 2000 | 9.604M |
December 31, 1999 | 0.1245M |
June 30, 1999 | 0.3047M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.1716M
Minimum
Jun 2022
167.29M
Maximum
Jun 2023
78.28M
Average
75.15M
Median
Cash from Financing (TTM) Benchmarks
Immutep Ltd | 13.70M |
Kazia Therapeutics Ltd | 7.850M |
Bionomics Ltd | -- |
Alterity Therapeutics Ltd | 33.78M |
Mesoblast Ltd | 74.50M |